Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Decraecker

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancers|December 24, 2021
Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on LenvatinibMarie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc
Journal of Hepatocellular Carcinoma|July 2, 2020
Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special ConsiderationsAudrey Debaillon Vesque, Marie Decraecker, Jean-Frédéric Blanc
Hepatobiliary & Pancreatic Diseases International : HBPD INT|January 14, 2026
Real-world impact of the management of advanced perihilar and extrahepatic cholangiocarcinoma on prognosisMarie Decraecker, Valérie Aurillac, Jean-Frédéric Blanc
Journal of Hepatocellular Carcinoma|April 29, 2026
Impact of Child Pugh B Stage for the Treatment of Advanced HCCMarie Decraecker, Heloise Bourien, Jean-Frédéric Blanc, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2026
From Theory to Practice: Which Biomarkers Are Ready for Predicting Response in Advanced HCC?Marie Decraecker, Jean-Frédéric Blanc, Samuel Amintas, et al.
Clinics and Research in Hepatology and Gastroenterology|July 29, 2021
Quality criteria for the measurement of liver stiffnessJérôme Boursier, Marie Decraecker, Marc Bourlière, et al.
Genes, Chromosomes & Cancer|June 15, 2026
Primary Tumor-Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal CancerAnaëlle Isnard, Marie Decraecker, Benjamin Fernandez, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2022
Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methodsMarie Decraecker, Dan Dutartre, Jean-Baptiste Hiriart, et al.
Frontiers in Oncology|January 1, 2026
Benefit and safety of capecitabine after resection of biliary tract cancer: a real-world study with propensity score matchingHugo Roussel, Sophie Le Joncour, Valerie Aurillac, et al.
Journal of Liver Cancer|May 14, 2026
Outcomes of Early-Stage HCC patients treated by resection or ablation: real-life data from the French administrative health care database (SNDS)Marie Decraecker, Boris Guiu, Emmanuel Boleslawski, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancers|December 24, 2021
Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on LenvatinibMarie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc
Journal of Hepatocellular Carcinoma|July 2, 2020
Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special ConsiderationsAudrey Debaillon Vesque, Marie Decraecker, Jean-Frédéric Blanc
Hepatobiliary & Pancreatic Diseases International : HBPD INT|January 14, 2026
Real-world impact of the management of advanced perihilar and extrahepatic cholangiocarcinoma on prognosisMarie Decraecker, Valérie Aurillac, Jean-Frédéric Blanc
Journal of Hepatocellular Carcinoma|April 29, 2026
Impact of Child Pugh B Stage for the Treatment of Advanced HCCMarie Decraecker, Heloise Bourien, Jean-Frédéric Blanc, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2026
From Theory to Practice: Which Biomarkers Are Ready for Predicting Response in Advanced HCC?Marie Decraecker, Jean-Frédéric Blanc, Samuel Amintas, et al.
Clinics and Research in Hepatology and Gastroenterology|July 29, 2021
Quality criteria for the measurement of liver stiffnessJérôme Boursier, Marie Decraecker, Marc Bourlière, et al.
Genes, Chromosomes & Cancer|June 15, 2026
Primary Tumor-Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal CancerAnaëlle Isnard, Marie Decraecker, Benjamin Fernandez, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2022
Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methodsMarie Decraecker, Dan Dutartre, Jean-Baptiste Hiriart, et al.
Frontiers in Oncology|January 1, 2026
Benefit and safety of capecitabine after resection of biliary tract cancer: a real-world study with propensity score matchingHugo Roussel, Sophie Le Joncour, Valerie Aurillac, et al.
Journal of Liver Cancer|May 14, 2026
Outcomes of Early-Stage HCC patients treated by resection or ablation: real-life data from the French administrative health care database (SNDS)Marie Decraecker, Boris Guiu, Emmanuel Boleslawski, et al.
Pageof 3